Development of Laponite® hydrogels for cisplatin delivery

Bibliographic Details
Main Author: Duarte, Ana Sofia de Gouveia
Publication Date: 2024
Format: Master thesis
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.13/5627
Summary: Cancer remains a major health concern worldwide and the development of effective therapies remains a challenge. Laponite® is a synthetic nanoclay that possesses properties such as easy functionalization, degradability, and biocompatibility. More importantly, Laponite® can form strongly thixotropic gels at higher concentrations which can be explored as an avenue to drug delivery. Amongst the drugs used for cancer therapy, cisplatin, a platinum-containing metallodrug, is especially used due to its mechanism of action, which involves interference with the cells’ DNA. The main goal of this work was to formulate hydrogels composed by Laponite for the delivery of cisplatin. These gels are aimed for topical application or, eventually, for direct injection in the tumor site. As such, the preparation of Laponite hydrogels was first optimized (regarding type of liquid medium, temperature, Laponite concentration, solvent pH vs gelation time and gel consistency and transparency) and the gels were then studied to assess their ability to load (different cisplatin concentrations were assayed) and release cisplatin (at two different environmental pH values). Furthermore, the gels’ cytotoxicity was evaluated in vitro in two cell lines, A2780 (human ovarian carcinoma) and its related cell line A2780cis (resistant to cisplatin). Cytotoxicity studies were carried out using two different approaches which mainly differed regarding the type of contact between the gels and the cells (direct and non-direct). Characterization of the gels by SEM/EDS showed that cisplatin enhances cohesion within the gels. Drug release was sustained but not sensitive to pH. Additionally, in vitro studies showed that non-loaded Laponite gels promoted cells’ viability and gels containing cisplatin were cytotoxic in a concentration-dependent manner. Even though it was not possible to distinguish the two approaches used in this work regarding cytotoxicity, it was possible to conclude that Laponite hydrogels are promising platforms for cisplatin delivery.
id RCAP_cf6d770e5b34421e52d8d5a9928ab40e
oai_identifier_str oai:digituma.uma.pt:10400.13/5627
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Development of Laponite® hydrogels for cisplatin deliveryLaponiteCisplatinHydrogelDrug releaseCytotoxicityCancerCisplatinaHidrogelLibertação de fármacoCitotoxicidadeCancroApplied Biochemistry.Faculdade de Ciências Exatas e da EngenhariaCancer remains a major health concern worldwide and the development of effective therapies remains a challenge. Laponite® is a synthetic nanoclay that possesses properties such as easy functionalization, degradability, and biocompatibility. More importantly, Laponite® can form strongly thixotropic gels at higher concentrations which can be explored as an avenue to drug delivery. Amongst the drugs used for cancer therapy, cisplatin, a platinum-containing metallodrug, is especially used due to its mechanism of action, which involves interference with the cells’ DNA. The main goal of this work was to formulate hydrogels composed by Laponite for the delivery of cisplatin. These gels are aimed for topical application or, eventually, for direct injection in the tumor site. As such, the preparation of Laponite hydrogels was first optimized (regarding type of liquid medium, temperature, Laponite concentration, solvent pH vs gelation time and gel consistency and transparency) and the gels were then studied to assess their ability to load (different cisplatin concentrations were assayed) and release cisplatin (at two different environmental pH values). Furthermore, the gels’ cytotoxicity was evaluated in vitro in two cell lines, A2780 (human ovarian carcinoma) and its related cell line A2780cis (resistant to cisplatin). Cytotoxicity studies were carried out using two different approaches which mainly differed regarding the type of contact between the gels and the cells (direct and non-direct). Characterization of the gels by SEM/EDS showed that cisplatin enhances cohesion within the gels. Drug release was sustained but not sensitive to pH. Additionally, in vitro studies showed that non-loaded Laponite gels promoted cells’ viability and gels containing cisplatin were cytotoxic in a concentration-dependent manner. Even though it was not possible to distinguish the two approaches used in this work regarding cytotoxicity, it was possible to conclude that Laponite hydrogels are promising platforms for cisplatin delivery.Tomás, Helena Maria Pires GasparRodrigues, João Manuel CunhaDigitUMaDuarte, Ana Sofia de Gouveia2024-03-122025-10-12T00:00:00Z2024-03-12T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.13/5627urn:tid:203569121enginfo:eu-repo/semantics/embargoedAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-24T16:52:08Zoai:digituma.uma.pt:10400.13/5627Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:40:54.904610Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Development of Laponite® hydrogels for cisplatin delivery
title Development of Laponite® hydrogels for cisplatin delivery
spellingShingle Development of Laponite® hydrogels for cisplatin delivery
Duarte, Ana Sofia de Gouveia
Laponite
Cisplatin
Hydrogel
Drug release
Cytotoxicity
Cancer
Cisplatina
Hidrogel
Libertação de fármaco
Citotoxicidade
Cancro
Applied Biochemistry
.
Faculdade de Ciências Exatas e da Engenharia
title_short Development of Laponite® hydrogels for cisplatin delivery
title_full Development of Laponite® hydrogels for cisplatin delivery
title_fullStr Development of Laponite® hydrogels for cisplatin delivery
title_full_unstemmed Development of Laponite® hydrogels for cisplatin delivery
title_sort Development of Laponite® hydrogels for cisplatin delivery
author Duarte, Ana Sofia de Gouveia
author_facet Duarte, Ana Sofia de Gouveia
author_role author
dc.contributor.none.fl_str_mv Tomás, Helena Maria Pires Gaspar
Rodrigues, João Manuel Cunha
DigitUMa
dc.contributor.author.fl_str_mv Duarte, Ana Sofia de Gouveia
dc.subject.por.fl_str_mv Laponite
Cisplatin
Hydrogel
Drug release
Cytotoxicity
Cancer
Cisplatina
Hidrogel
Libertação de fármaco
Citotoxicidade
Cancro
Applied Biochemistry
.
Faculdade de Ciências Exatas e da Engenharia
topic Laponite
Cisplatin
Hydrogel
Drug release
Cytotoxicity
Cancer
Cisplatina
Hidrogel
Libertação de fármaco
Citotoxicidade
Cancro
Applied Biochemistry
.
Faculdade de Ciências Exatas e da Engenharia
description Cancer remains a major health concern worldwide and the development of effective therapies remains a challenge. Laponite® is a synthetic nanoclay that possesses properties such as easy functionalization, degradability, and biocompatibility. More importantly, Laponite® can form strongly thixotropic gels at higher concentrations which can be explored as an avenue to drug delivery. Amongst the drugs used for cancer therapy, cisplatin, a platinum-containing metallodrug, is especially used due to its mechanism of action, which involves interference with the cells’ DNA. The main goal of this work was to formulate hydrogels composed by Laponite for the delivery of cisplatin. These gels are aimed for topical application or, eventually, for direct injection in the tumor site. As such, the preparation of Laponite hydrogels was first optimized (regarding type of liquid medium, temperature, Laponite concentration, solvent pH vs gelation time and gel consistency and transparency) and the gels were then studied to assess their ability to load (different cisplatin concentrations were assayed) and release cisplatin (at two different environmental pH values). Furthermore, the gels’ cytotoxicity was evaluated in vitro in two cell lines, A2780 (human ovarian carcinoma) and its related cell line A2780cis (resistant to cisplatin). Cytotoxicity studies were carried out using two different approaches which mainly differed regarding the type of contact between the gels and the cells (direct and non-direct). Characterization of the gels by SEM/EDS showed that cisplatin enhances cohesion within the gels. Drug release was sustained but not sensitive to pH. Additionally, in vitro studies showed that non-loaded Laponite gels promoted cells’ viability and gels containing cisplatin were cytotoxic in a concentration-dependent manner. Even though it was not possible to distinguish the two approaches used in this work regarding cytotoxicity, it was possible to conclude that Laponite hydrogels are promising platforms for cisplatin delivery.
publishDate 2024
dc.date.none.fl_str_mv 2024-03-12
2024-03-12T00:00:00Z
2025-10-12T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.13/5627
urn:tid:203569121
url http://hdl.handle.net/10400.13/5627
identifier_str_mv urn:tid:203569121
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598796467011584